Mytrus secures patent position for home-based clinical trials
This article was originally published in Scrip
The San Francisco-based software firm Mytrus has bought the exclusive rights to Boston University's patented method for managing clinical trials over the internet from one single co-ordinating centre, enabling them the competitive advantage to offer clients a completely protected study performed only through electronic means.
You may also be interested in...
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"